medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2006, Number 3

<< Back Next >>

Acta Med 2006; 4 (3)

Classic severe idiopathic leukocyte vasculitis

Arévalo MFG, Badia FJJ

Language: Spanish
References: 25
Page: 191-192
PDF size: 32.48 Kb.


ABSTRACT

Classic leukocytoclastic vasculitis (LV) is the most common cutaneous vasculitis. Systemic entanglement is very common, usually affecting the musculoskeletal, gastrointestinal, renal, respiratory and peripheral nervous system. It may be idiopathic or associated to drugs, systemic vasculitic syndromes, autoimmune diseases, infections and neoplasias. We report a case of LV with clinical manifestations where it was not found a demonstrable cause.


REFERENCES

  1. Sunderkotter C, Bonsmann G, Sindrilaru A, Lugar T. Management of leukocytoclastic vasculitis. J Dermatolog Treat 2005; 16(4): 193-206.

  2. Gay M, Ball Jr, Gene. Vasculitis. In: Koopman WJ. Arthritis and Allied Conditions, a Textbook of Rheumatology. 13th Edition. William & Wilkins, 1997: 1491-1524.

  3. Gonzalez EB, Conn DL. Hypersensitivity Vasculitis (Small-Vessel Cutaneous Vasculitis). In: Kelley‘s Textbook of Rheumatology. 6th Edition. W.B. Saunders Company, 2001: 1197-1203.

  4. Bayer-Garner IB, Smoller BR. Leukocytoclastic (small vessel) vasculitis in multiple myeloma. Clin Exp Dermatol 2003; 28(5): 521-4.

  5. Gibson LE, Su WP. Cutaneous vasculitis. Rheum Dis Clin North Am 1990; 16: 309.

  6. Sams WM Jr, Thorne EG, Small P, Mass MF, McIntosh RM, Stanford RE. Leukocytoclastic vasculitis. Arch Dermatol 1976; 112(2): 219-26.

  7. Doyle MK, Cuellar ML. Drug-induced vasculitis. Expert Opin Drug Saf 2003; 2(4): 401-9.

  8. Mohan N, Edwards ET, Cupps TR, Slifman N, Lee JH, Siegel JN, Braun MM. Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents. J Rheumatol 2004; 31(10): 1955-8.

  9. Stefan Gasser, Max Kuhn, Rudolf Speich. Severe necrotizing leucocytoclastic vasculitis in a patient taking bosentan. BMJ 2004; 329: 430 (21 August).

  10. Odemis E, Kalyoncu M, Okten A, Yildiz K. Azithromycin-induced leukocytoclastic vasculitis. J Rheumatol 2003; 30(10): 2292.

  11. Barksdale SK, Hallahan CW, Kerr GS, Fauci AS, Stern JB, Travis WD. Cutaneous pathology in Wegener’s granulomatosis. A clinicopathologic study of 75 biopsies in 46 patients. Am J Surg Pathol 1995; 19(2): 161-72.

  12. Mangold MC, Callen JP. Cutaneous leukocytoclastic vasculitis associated with active Wegener’s granulomatosis. J Am Acad Dermatol 1992; 26(4): 579-84.

  13. Ramos-Casals M, Anaya JM, Garcia-Carrasco M, Rosas J, Bove A, Claver G, Diaz LA, Herrero C, Font J. Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore) 2004; 83(2): 106.

  14. Perez C, Guarch R, Rodrigo M, Gallego M, Ormazabal O. Successful treatment of leucocytoclastic vasculitis and pancytopenia secondary to systemic lupus erythematosus with intravenous immunoglobulin. Br J Dermatol Jul; 147(1): 180-2.

  15. Sanchez-Perez J, Penas PF, Rios-Buceta L, Fernandez-Herrera J, Fraga J, Garcia-Diez A. Leukocytoclastic vasculitis in subacute cutaneous lupus erythematosus: clinicopathologic study of three cases and review of the literature. Dermatology 1996; 193(3): 230-5.

  16. Magro CM, Crowson AN. The spectrum of cutaneous lesions in rheumatoid arthritis: a clinical and pathological study of 43 patients. J Cutan Pathol 2003; 30(1): 1-10.

  17. Cascina A, Marone Bianco A, Mangiarotti P, Montecucco CM, Meloni F. Cutaneous vasculitis and reactive arthritis following respiratory infection due to Chlamydia pneumoniae: report of a case. Clin Exp Rheumatol 2002; 20(6): 845-7.

  18. Kanai K, Kuwabara S, Mori M, Arai K, Yamamoto T, Hattori T. Leukocytoclastic-vasculitic neuropathy associated with chronic Epstein-Barr virus infection. Muscle Nerve 2003; 27(1): 113-6.

  19. Cem Ar, Soysal T, Hatemi G, Salihoglu A, Yazici H, Ulku B. Successful management of cryoglobulinemia-induced leukocytoclastic vasculitis with thalidomide in a patient with multiple myeloma. Ann Hematol 2005; 84(9): 609-13.

  20. Curgunlu A, Karter Y, Uvanik O, Tunckale A, Curgunlu S. Leukocytoclastic vasculitis and renal cell carcinoma. Intern Med 2004; 43(3): 256-7.

  21. Lotti T, Ghersetich I, Comacchi C, Jorizzo JL. Cutaneous smallvessel vasculitis. J Am Acad Dermatol 1998; 39(5): 667-87.

  22. Russell JP, Weenig RH. Primary Cutaneous Small Vessel Vasculitis. Curr Treat Options Cardiovasc Med 2004; 6(2): 139-149.

  23. Fredenberg MF, Malkinson FD. Sulfone therapy in the treatment of leukocytoclastic vasculitis. Report of three cases. J Am Acad Dermatol 1987; 16(4): 772-8.

  24. Sullivan TP, King LE Jr, Boyd AS. Colchicine in dermatology. J Am Acad Dermatol 1998; 39(6): 993-9.

  25. Callen JP. Colchicine is effective in controlling chronic cutaneous leukocytoclastic vasculitis. J Am Acad Dermatol 1985; 13(2): 193-200.




2020     |     www.medigraphic.com